Detalles de la búsqueda
1.
[Spinal motor segment labeling with a mixture of n-butyl-2-cyanoacrylate and iohexol in determining the level of thoracic spine surgery]. / Opyt markirovaniya pozvonochno-dvigatel'nogo segmenta smes'yu kleya na osnove n-butil-2-tsianoakrilata s iogeksolom pri opredelenii urovnya operativnogo vmeshatel'stva na grudnom otdele pozvonochnika.
Zh Vopr Neirokhir Im N N Burdenko
; 85(6): 62-67, 2021.
Artículo
en Ruso
| MEDLINE | ID: mdl-34951761
2.
[Local experience of IL-6 pathway inhibition with satralizumab for patients with neuromyelitis optica spectrum disorder]. / Lokal'nyi opyt primeneniya preparata satralizumab, podavlyayushchego put' IL-6, dlya terapii zabolevanii spektra optikoneiromielita.
Zh Nevrol Psikhiatr Im S S Korsakova
; 122(7. Vyp. 2): 68-72, 2022.
Artículo
en Ruso
| MEDLINE | ID: mdl-35912559
3.
[Approaches to vaccine prevention in multiple sclerosis]. / Vaktsinoprofilaktika pri rasseyannom skleroze.
Zh Nevrol Psikhiatr Im S S Korsakova
; 122(9): 29-36, 2022.
Artículo
en Ruso
| MEDLINE | ID: mdl-36168685
4.
[Registry-based comparison of multiple sclerosis epidemiology trend data in 1999 and 2019: the case of Yaroslavl]. / Dinamika osnovnykh epidemiologicheskikh pokazatelei rasseyannogo skleroza po rezul'tatam sravneniya registrov patsientov 1999 i 2019 gg. v Yaroslavle.
Zh Nevrol Psikhiatr Im S S Korsakova
; 120(7. Vyp. 2): 48-53, 2020.
Artículo
en Ruso
| MEDLINE | ID: mdl-32844630
5.
The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.
Neurosci Behav Physiol
; 39(1): 25-30, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19089638
6.
State of the cervical section of the spinal cord in patients with remitting multiple sclerosis during immunomodulatory treatment.
Neurosci Behav Physiol
; 39(1): 47-51, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19089623
7.
[Acute back pain: minimizing the risks of therapy as the basis for effective treatment]. / Ostrye boli v spine: minimizatsiia riskov terapii kak osnova éffektivnogo lecheniia.
Zh Nevrol Psikhiatr Im S S Korsakova
; 119(11): 80-85, 2019.
Artículo
en Ruso
| MEDLINE | ID: mdl-31851177
8.
[The pegylated form of interferon beta in the treatment of multiple sclerosis]. / Pegilirovannaia forma interferona beta v terapii rasseiannogo skleroza.
Zh Nevrol Psikhiatr Im S S Korsakova
; 119(8): 136-141, 2019.
Artículo
en Ruso
| MEDLINE | ID: mdl-31626182
9.
[Steps to personalized therapy of multiple sclerosis: predicting safety of treatment using mathematical modeling]. / Shagi k personifitsirovannoi terapii rasseiannogo skleroza: prognozirovanie bezopasnosti terapii s ispol'zovaniem matematicheskogo modelirovaniia.
Zh Nevrol Psikhiatr Im S S Korsakova
; 118(8. Vyp. 2): 70-76, 2018.
Artículo
en Ruso
| MEDLINE | ID: mdl-30160671
10.
Possible mechanisms of the formation of chronic fatigue syndrome in the clinical picture of multiple sclerosis.
Neurosci Behav Physiol
; 37(3): 215-9, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17294096
11.
[An effect of disease-modifying drugs on the development of children born to mothers with multiple sclerosis]. / Vliianie na razvitie rebenka terapii preparatami, izmeniaiushchimi techenie rasseiannogo skleroza, u materei s rasseiannym sklerozom.
Zh Nevrol Psikhiatr Im S S Korsakova
; 117(2. Vyp. 2): 85-91, 2017.
Artículo
en Ruso
| MEDLINE | ID: mdl-28617366
12.
[Polymorphic variants of the immune response genes as risk factors for primary progressive multiple sclerosis]. / Polimorfnye varianty genov immunnogo otveta kak faktory riska razvitiia pervichno-progressiruiushchego rasseiannogo skleroza.
Zh Nevrol Psikhiatr Im S S Korsakova
; 117(2. Vyp. 2): 14-21, 2017.
Artículo
en Ruso
| MEDLINE | ID: mdl-28617357
13.
[A place of first-line drugs in treatment of multiple sclerosis]. / Mesto preparatov pervoi linii v lechenii rasseiannogo skleroza.
Zh Nevrol Psikhiatr Im S S Korsakova
; 116(12): 145-151, 2016.
Artículo
en Ruso
| MEDLINE | ID: mdl-28635741
14.
[The results of an open prospective study of ß-interferon biosimilars (an Yaroslavl' cohort)]. / Rezul'taty otkrytogo prospektivnogo issledovaniya bioanalogov ß-interferonov.
Zh Nevrol Psikhiatr Im S S Korsakova
; 116(2 Pt 2): 68-73, 2016.
Artículo
en Ruso
| MEDLINE | ID: mdl-27070364
15.
[Current strategy of treatment of cognitive impairment: potential points of application of drugs used for treatment of cognitive functions].
Zh Nevrol Psikhiatr Im S S Korsakova
; 114(3): 114-21, 2014.
Artículo
en Ruso
| MEDLINE | ID: mdl-24795931
16.
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs]. / Unifikatsiia otsenki pobochnykh éffektov terapii preparatami, izmeniaiushchimi techenie rasseiannogo skleroza.
Zh Nevrol Psikhiatr Im S S Korsakova
; 114(2 Pt 2): 78-82, 2014.
Artículo
en Ruso
| MEDLINE | ID: mdl-24662361
17.
[Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region].
Zh Nevrol Psikhiatr Im S S Korsakova
; 112(8): 27-33, 2012.
Artículo
en Ruso
| MEDLINE | ID: mdl-23096035
18.
[Differential diagnosis of late-stage neuroborreliosis with affection of the central nervous system].
Zh Nevrol Psikhiatr Im S S Korsakova
; 112(9 Pt 2): 34-9, 2012.
Artículo
en Ruso
| MEDLINE | ID: mdl-23235422
19.
[Multiple sclerosis or recurrent disseminated encephalomyelitis?].
Zh Nevrol Psikhiatr Im S S Korsakova
; 109(7 Suppl 2): 79-85, 2009.
Artículo
en Ruso
| MEDLINE | ID: mdl-19891351
20.
[A neurovascular unit as a point of action of some vasoactive and neuroprotective drugs].
Zh Nevrol Psikhiatr Im S S Korsakova
; 112(9): 103-7, 2012.
Artículo
en Ruso
| MEDLINE | ID: mdl-23373082